Major amputation for intractable extremity melanoma after failure of isolated limb perfusion

Eur J Surg Oncol. 2005 Feb;31(1):95-9. doi: 10.1016/j.ejso.2004.10.003.

Abstract

Aim: The aim of this study was to analyse indications and results of amputation for intractable extremity melanoma after failure of isolated limb perfusion (ILP).

Methods: Between 1978 and 2001, 451 patients with loco-regional advanced extremity melanoma underwent 505 ILPs. Amputation of the affected extremity had to be carried out for intractable recurrent disease in 11 of these patients.

Results: The indications for amputation were uncontrollable pain (n=2), extensive loco-regional tumour progression (n=4), loss of ankle function due to local tumour growth (n=1), and ulcerating and fungating lesions, not responding to other treatments (n=4). Four patients developed stump recurrence after amputation. Ten patients died of melanoma metastases after a median of 11 months (range 2-110 months). Two patients survived more than 5 years after amputation.

Conclusions: Major amputation is rarely indicated for intractable extremity melanoma but long-term survival can be achieved in selected patients.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Amputation, Surgical*
  • Antineoplastic Agents / administration & dosage
  • Chemotherapy, Cancer, Regional Perfusion
  • Female
  • Humans
  • Hyperthermia, Induced
  • Leg / surgery*
  • Male
  • Melanoma / drug therapy
  • Melanoma / surgery*
  • Melphalan / administration & dosage
  • Middle Aged
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / surgery*
  • Treatment Failure

Substances

  • Antineoplastic Agents
  • Melphalan